Promoter Methylation of Two HOXA۹ and NISCH Genes in Opium Users

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 105

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AHJK-15-2_002

تاریخ نمایه سازی: 9 مرداد 1403

چکیده مقاله:

Background: Opiate abuse has been critically increased in the world, especially in Iran. Owing to the association of opiate use with multiple human cancers and neurological disorders, seeking for genetic and epigenetic effects of opium can pave the way for early diagnosis of major health defects in addicted users. Accordingly, the present study aimed to determine the methylation status of the promoter of two genes, which are actively involved in neurodevelopment and cancer evolution.Methods: DNA was isolated from peripheral blood of ۲۸ opium abusers and ۱۹ healthy controls and then subjected to sonication. Sonicated DNAs undergone methylated DNA immunoprecipitation-real time polymerase chain reaction (MeDIP-Real Time PCR) using specific primer pairs designed for HOXA۹ and NISCH genes. Obtained data were analyzed using SPSS software.Findings: HOXA۹ and NISCH genes were found to be significantly methylated in addicted users compared to controls (P<۰.۰۰۱) which was significantly associated with the mean of the age regarding HOXA۹ gene (P=۰.۰۰۲). Neither opium amount nor duration or route of using was associated with the methylation status of HOXA۹ or NISCH genes.Conclusion: Hypermethylation of HOXA۹ and NISCH genes as tumor suppressor in opium-addicted individuals can be considered as confirmatory evidence for carcinogenesis of opium. Further studies are required to figure out the role of epigenetic alterations in cancer evolution among opium users.

نویسندگان

Majid Mahmoodi

۱. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran ۲. Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Fatemeh Karami

۱.Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran ۲.Department of Medical Genetics, Applied Biophotonics Research Center, Science and Research Branch, Islamic Azad University,

Hamidreza Abdollahi

Department of Medical Genetics, Applied Biophotonics Research Center, Science and Research Branch, Islamic Azad University, Tehran, Iran

Navidreza Giahi

Akhtar Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Kouros Divsalar

Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

Amin Honarmand

Department of Emergency Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran

Mohammad Hossein Modarressi

Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • World Drug Report ۲۰۲۱. Austria: United Nations Publication; ۲۰۲۱ ...
  • Farooq SA, Rasooly MH, Abidi SH, Modjarrad K, Ali S. ...
  • Shayan NA, Niazi AU, Moheb H, Mohammadi H, Ahmad Saddiqi ...
  • Mansouri M, Naghshi S, Parsaeian M, Ghajarieh Sepanlou S, Poustchi ...
  • Afshari M, Janbabaei G, Bahrami MA, Moosazadeh M. Opium and ...
  • Barlass U, Deshmukh A, Beck T, Bishehsari F. Opioid use ...
  • Rashidian H, Zendehdel K, Kamangar F, Malekzadeh R, Haghdoost AA. ...
  • Rezaei S, Bakhshani NM, Fanaei H, Trofimova I. Opium effect ...
  • Browne CJ, Godino A, Salery M, Nestler EJ. Epigenetic mechanisms ...
  • Ghodsi M, Shahmohammadi M, Modarressi MH, Karami F. Investigation of ...
  • Quinonez SC, Innis JW. Human HOX gene disorders. Mol Genet ...
  • Alvarado-Ruiz L, Martinez-Silva MG, Torres-Reyes LA, PinaSanchez P, Ortiz-Lazareno P, ...
  • Gurung PMS, Barnett AR, Wilson JS, Hudson J, Ward DG, ...
  • Liu B, Ricarte Filho J, Mallisetty A, Villani C, Kottorou ...
  • Shen N, Du J, Zhou H, Chen N, Pan Y, ...
  • Zhang Z, Chen P, Xie H, Cao P. Using circulating ...
  • Brait M, Loyo M, Rosenbaum E, Ostrow KL, Markova A, ...
  • Krishnamurthy K, Mishra TK, Saxena A, Daga MK, Khurana N, ...
  • Maziveyi M, Alahari SK. Breast cancer tumor suppressors: a special ...
  • Li S, Wu N, Zhao TY, Lu GY, Wang ZY, ...
  • Ostrow KL, Michailidi C, Guerrero-Preston R, Hoque MO, Greenberg A, ...
  • Karami F, Noori-Daloii MR, Omidfar K, Tabrizi M, Hantooshzadeh S, ...
  • Kozlenkov A, Jaffe AE, Timashpolsky A, Apontes P, Rudchenko S, ...
  • Ji H, Liu G, Xu X, Liu H, Xu L, ...
  • Sandoval-Sierra JV, Salgado García FI, Brooks JH, Derefinko KJ, Mozhui ...
  • Muñoa-Hoyos I, Araolaza M, Urizar-Arenaza I, Gianzo M, Irazusta J, ...
  • Zhang J, Fan Y, Zhou J, Ma T, Gao K, ...
  • Kosciuczuk U, Knapp P, Lotowska-Cwiklewska AM. Opioidinduced immunosuppression and carcinogenesis ...
  • Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, ...
  • نمایش کامل مراجع